UC Davis Comprehensive Cancer Center https://www.ucdmc.ucdavis.edu/publish/rss/{$key} UC Davis Comprehensive Cancer Center news UC Davis Comprehensive Cancer Center https://www.ucdmc.ucdavis.edu/global/images/wordmarks/cancer_center.gif https://www.ucdmc.ucdavis.edu/publish/rss/cancercenter UC Davis Comprehensive Cancer Center news Research linking obesity to immune function and disease gets funding boost https://www.ucdmc.ucdavis.edu/publish/news/cancer/11829/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11829 SACRAMENTO, Calif. (February 23, 2017) - Researchers at UC Davis have received $3.2 million in federal funds to further investigate how obesity and inflammation affect the body’s immune system in fighting cancer. Thu, 23 Feb 2017 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11829 Dorsey Griffith 2017-02-23T00:00:00Z UC Davis study finds mold, bacterial contaminants in medical marijuana samples https://www.ucdmc.ucdavis.edu/publish/news/cancer/11791/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11791 SACRAMENTO, Calif. (February 7, 2017) - UC Davis physician researchers have found that medical marijuana contains multiple bacterial and fungal pathogens that may cause serious and even fatal infections. They warn that smoking, vaping or inhaling aerosolized marijuana could pose a grave risk to patients, especially those with leukemia, lymphoma, AIDS or conditions requiring immune-suppressing therapies. Tue, 07 Feb 2017 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11791 Carole Gan 2017-02-07T00:00:00Z UC Davis Cancer Care Network welcomes two new sites https://www.ucdmc.ucdavis.edu/publish/news/cancer/11756/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11756 SACRAMENTO, Calif. (January 26, 2017) - The UC Davis Health Cancer Care Network of community oncology programs has expanded to include Barton Health in Lake Tahoe and Ridgecrest Regional Hospital in the southeastern Sierra. Thu, 26 Jan 2017 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11756 Dorsey Griffith 2017-01-26T00:00:00Z Faulty DNA error correction genes set stage for familial gastric cancer https://www.ucdmc.ucdavis.edu/publish/news/cancer/11743/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11743 SACRAMENTO, Calif. (January 19, 2017) - A large team of researchers from UC Davis and several European and Latin American institutions have identified genetic variations that contribute to familial gastric cancer. These inherited mutations, which affect the PALB2, BRCA1 and RAD51C genes and have been implicated in other cancer types, impair a critical DNA repair mechanism called homologous recombination. These findings could improve preventive care, as well as provide targets for new therapies. The study was published last month in the journal Gastroenterology.  Thu, 19 Jan 2017 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11743 Dorsey Griffith 2017-01-19T00:00:00Z Many late-stage lung cancer patients do not get treatment https://www.ucdmc.ucdavis.edu/publish/news/cancer/11742/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11742 SACRAMENTO, Calif. (January 18, 2017) - A national study by researchers at UC Davis Comprehensive Cancer Center has found that a significant number of lung cancer patients are not receiving treatment. Based on data between 1998 and 2012 from the National Cancer Database, 21 percent of patients (190,539) with non-small cell lung cancer (NSCLC) received no specific cancer treatment, such as chemotherapy, radiotherapy or surgery. Many of the untreated patients were women, elderly, minorities, low income and uninsured. Wed, 18 Jan 2017 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11742 Doreen Purvis 2017-01-18T00:00:00Z World's first total-body PET scanner takes big step forward https://www.ucdmc.ucdavis.edu/publish/news/cancer/11744/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11744 SACRAMENTO, Calif. (January 17, 2017) - The UC Davis-based EXPLORER consortium, which aims to build a revolutionary total-body PET (positron emission tomography) scanner, has announced the selection of two industry partners to help build the prototype device. They are United Imaging Healthcare America, a North American subsidiary of Shanghai United Imaging Healthcare, and SensL Technologies of Cork, Ireland. Tue, 17 Jan 2017 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11744 Dorsey Griffith 2017-01-17T00:00:00Z UC Davis and nation's cancer centers jointly endorse updated HPV vaccine recommendations https://www.ucdmc.ucdavis.edu/publish/news/cancer/11722/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11722 SACRAMENTO, Calif. (January 11, 2017) - Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), UC Davis Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the U.S. Centers for Disease Control and Prevention (CDC). Wed, 11 Jan 2017 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11722 Dorsey Griffith 2017-01-11T00:00:00Z UC Davis Health welcomes Beijing medical equipment company https://www.ucdmc.ucdavis.edu/publish/news/cancer/11721/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11721 SACRAMENTO, Calif. (January 9, 2017) - UC Davis Health has entered into an agreement with Top Grade Health Care to establish a translational research and development center to advance the treatment of patients with cancer. Mon, 09 Jan 2017 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11721 Charles Casey 2017-01-09T00:00:00Z Immunotherapy improves survival in late-stage lung cancer patients https://www.ucdmc.ucdavis.edu/publish/news/cancer/11671/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11671 SACRAMENTO, Calif. (December 12, 2016) - A large trial by UC Davis professor David Gandara has found that the immunotherapy atezolizumab was superior to chemotherapy for patients with advanced non-small-cell lung cancer. Mon, 12 Dec 2016 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11671 Dorsey Griffith 2016-12-12T00:00:00Z Kindness, compassion key to cancer center pharmacy program https://www.ucdmc.ucdavis.edu/publish/news/cancer/11623/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11623 SACRAMENTO, Calif. (November 16, 2016) - Jacquelyn Conway, a mother who enjoys taking long walks and cooking organic meals, was told she had invasive breast cancer In August 2012. That began an arduous series of cancer treatments starting with chemotherapy – and a determined approach to survival.  Wed, 16 Nov 2016 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11623 Dorsey Griffith 2016-11-16T00:00:00Z Cancer research pioneer to speak on therapy advances https://www.ucdmc.ucdavis.edu/publish/news/cancer/11617/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11617 SACRAMENTO, Calif. (November 15, 2016) - Alan Ashworth, renowned basic cancer scientist and president of the UCSF Helen Diller Comprehensive Cancer Center, will present a talk on synthetic lethal approaches to cancer therapy Nov. 30 at UC Davis. Tue, 15 Nov 2016 00:00:00 PST https://www.ucdmc.ucdavis.edu/publish/news/cancer/11617 Dorsey Griffith 2016-11-15T00:00:00Z Breast cancer patients have new surgery option with radioactive seed https://www.ucdmc.ucdavis.edu/publish/news/cancer/11591/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11591 SACRAMENTO, Calif. (November 3, 2016) - UC Davis Comprehensive Cancer Center now offers a new technique for breast cancer patients undergoing surgery to remove breast cancer that may improve cosmetic outcomes and the patient’s surgery experience. Thu, 03 Nov 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11591 Caitlin Scordalakis 2016-11-03T00:00:00Z Terminally ill cancer patients fare poorly after surgery https://www.ucdmc.ucdavis.edu/publish/news/cancer/11561/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11561 SACRAMENTO, Calif. (October 25, 2016) - Patients with disseminated advanced cancer who undergo surgery are far more likely to endure long hospital stays and readmissions, referrals to extended care facilities and death, UC Davis researchers have found. Tue, 25 Oct 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11561 Dorsey Griffith 2016-10-25T00:00:00Z Sexual pain in women after cancer is common, and too often ignored https://www.ucdmc.ucdavis.edu/publish/news/cancer/11550/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11550 SACRAMENTO, Calif. (October 20, 2016) - Painful sex in women after cancer treatment is relatively common, often treatable and needs to be addressed by medical providers, a UC Davis oncologist and researcher suggests. Thu, 20 Oct 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11550 Dorsey Griffith 2016-10-20T00:00:00Z Workshop set for young adults with cancer https://www.ucdmc.ucdavis.edu/publish/news/cancer/11542/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11542 SACRAMENTO, Calif. (October 18, 2016) - Young adults dealing with the effects of cancer are invited to attend Pushing Past Cancer, a free day of education and motivation, on Saturday, Nov. 5, from 9:30 a.m. to 5 p.m. at the UC Davis Sacramento campus. The event is open to cancer patients ages 18-40, their support persons and medical professionals. Tue, 18 Oct 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11542 Dorsey Griffith 2016-10-18T00:00:00Z NIH Precision Medicine Initiative Cohort Program Expands in California https://www.ucdmc.ucdavis.edu/publish/news/cancer/11535/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11535 SACRAMENTO, Calif. (October 13, 2016) - The National Institutes of Health (NIH) has named the California Precision Medicine Consortium as a regional medical center group in the national network of health care provider organizations that will implement the Precision Medicine Initiative (PMI) Cohort Program. Thu, 13 Oct 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11535 Dorsey Griffith 2016-10-13T00:00:00Z Cancer Care Network symposium focuses on precision medicine and end-of-life options https://www.ucdmc.ucdavis.edu/publish/news/cancer/11515/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11515 SACRAMENTO, Calif. (October 4, 2016) - More than 80 people attended the 4th annual Cancer Care Network Symposium Saturday at the UC Davis Comprehensive Cancer Center auditorium to explore key topics in cancer care, including the new End of Life Option Act.  Tue, 04 Oct 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11515 Dorsey Griffith 2016-10-04T00:00:00Z Lam obtains major federal grants https://www.ucdmc.ucdavis.edu/publish/news/cancer/11485/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11485 SACRAMENTO, Calif. (September 23, 2016) - Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has received two major cancer research grants totaling more than $3 million. Fri, 23 Sep 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11485 Dorsey Griffith 2016-09-23T00:00:00Z Kit Lam appointed to NCI Board of Scientific Counselors https://www.ucdmc.ucdavis.edu/publish/news/cancer/11470/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11470 SACRAMENTO, Calif. (September 20, 2016) - Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has been appointed to the National Cancer Institute’s Basic Science Board of Scientific Counselors (BSC). Tue, 20 Sep 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11470 Dorsey Griffith 2016-09-20T00:00:00Z Voices of patients and oncologists must be heard, study shows https://www.ucdmc.ucdavis.edu/publish/news/cancer/11452/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11452 SACRAMENTO, Calif. (September 9, 2016) - Training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in JAMA Oncology. Fri, 09 Sep 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11452 Karen Finney 2016-09-09T00:00:00Z Ovarian cancer event ready to "ROC" Sept. 18 https://www.ucdmc.ucdavis.edu/publish/news/cancer/11447/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11447 SACRAMENTO, Calif. (September 8, 2016) - Marking Ovarian Cancer Awareness Month and the need for more research and education about the disease, Let’s ROC, the annual 5K run is set for Sunday, Sept. 18 at 8 a.m. Thu, 08 Sep 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11447 Dorsey Griffith 2016-09-08T00:00:00Z Cancer Center oral therapy adherence program wins Innovative Pharmacy Practice Award https://www.ucdmc.ucdavis.edu/publish/news/cancer/11445/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11445 SACRAMENTO, Calif. (September 7, 2016) - The cancer center's pharmacist-driven oral anti-cancer medication adherence program, led by Iris C. Zhao, has earned the 2016 California Society of Health System Pharmacist’s (CSHP) Innovative Pharmacy Practice Award. Wed, 07 Sep 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11445 Mark De Anda 2016-09-07T00:00:00Z UC Davis K12 scholars funded for cancer research https://www.ucdmc.ucdavis.edu/publish/news/cancer/11436/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11436 SACRAMENTO, Calif. (September 6, 2016) - The National Cancer Institute has again funded the K12 Paul Calabresi Clinical Oncology Training Grant to promote and sustain the development of young cancer scientists from diverse fields and from laboratories and clinics across both UC Davis campuses. Tue, 06 Sep 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11436 Dorsey Griffith 2016-09-06T00:00:00Z IPHI report shows impact of cancer screening in California over past 15 years https://www.ucdmc.ucdavis.edu/publish/news/cancer/11421/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11421 SACRAMENTO, Calif. (August 31, 2016) - A new report from the UC Davis Institute for Population Health Improvement (IPHI) shows the impact of cancer screening over the past 15 years, identifying areas where increased screening and other cancer-control efforts would save lives and significantly benefit population health. Wed, 31 Aug 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11421 Carole Gan 2016-08-31T00:00:00Z Lay educators help boost colorectal screening rates in Hmong https://www.ucdmc.ucdavis.edu/publish/news/cancer/11416/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11416 SACRAMENTO, Calif. (August 26, 2016) - Hmong Americans are more likely to understand the importance of colorectal cancer screening and to get screened when they’re provided information by specially trained Hmong lay health educators, new research from UC Davis has found. Fri, 26 Aug 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11416 Dorsey Griffith 2016-08-26T00:00:00Z UC Davis among the top for cancer, again https://www.ucdmc.ucdavis.edu/publish/news/cancer/11408/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11408 SACRAMENTO, Calif. (August 22, 2016) - Becker’s Hospital Review has named UC Davis Health System one of 100 in the country with “great oncology programs.” Mon, 22 Aug 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11408 Dorsey Griffith 2016-08-22T00:00:00Z UC Davis scientists awarded $1 million grant for prostate cancer research https://www.ucdmc.ucdavis.edu/publish/news/cancer/11362/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11362 SACRAMENTO, Calif. (August 5, 2016) - The Prostate Cancer Foundation and Movember, the global charity that has raised hundreds of millions for men’s health research and programs, have delivered $1 million to UC Davis prostate cancer researchers. Fri, 05 Aug 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11362 Dorsey Griffith 2016-08-05T00:00:00Z Hybrid treatment hunts down and kills leukemia cells https://www.ucdmc.ucdavis.edu/publish/news/cancer/11341/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11341 SACRAMENTO, Calif. (July 28, 2016) - Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease. Thu, 28 Jul 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11341 Dorsey Griffith 2016-07-28T00:00:00Z De Vere White to serve on prestigious NIH panel https://www.ucdmc.ucdavis.edu/publish/news/cancer/11329/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11329 SACRAMENTO, Calif. (July 26, 2016) - Ralph de Vere White, who retired in June as director of the UC Davis Comprehensive Cancer Center, has been named to a key committee at the National Institute of Health (NIH). Tue, 26 Jul 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11329 Dorsey Griffith 2016-07-26T00:00:00Z Player-in-chief https://www.ucdmc.ucdavis.edu/publish/news/cancer/11321/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11321 SACRAMENTO, Calif. (July 21, 2016) - The play area in the pediatric infusion center is buzzing with activity. Kids are building, coloring, reading and, most importantly, laughing. Not just patients, but parents and siblings, too. The play area isn’t just a haphazard jumble of donated toys and books, it’s a space specially designed by the cancer center’s resident child life specialist and expert on fun, Ellen Meuchel. Thu, 21 Jul 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11321 Dorsey Griffith 2016-07-21T00:00:00Z Oncologists and cancer patients often differ in prognosis perceptions https://www.ucdmc.ucdavis.edu/publish/news/cancer/11307/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11307 SACRAMENTO, Calif. (July 14, 2016) - Patients with stage III or IV cancer report far more optimistic expectations for survival than their oncologists thought they had communicated, according to new research published today in JAMA Oncology. Effective communication between doctors and their patients who could be nearing the end of their lives is crucial, according to the authors, since this is when quality-of-life decisions merge with discussions about treatment options. Thu, 14 Jul 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11307 Karen Finney 2016-07-14T00:00:00Z Lily Chiquet Strength Foundation, Inc. honors memory of child with donation https://www.ucdmc.ucdavis.edu/publish/news/cancer/11297/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11297 SACRAMENTO, Calif. (July 14, 2016) - Lily Chiquet would have been 4 this week. Thu, 14 Jul 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11297 Caitlin Scordalakis 2016-07-14T00:00:00Z Endowment for promising students honors de Vere White https://www.ucdmc.ucdavis.edu/publish/news/cancer/11275/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11275 SACRAMENTO, Calif. (June 29, 2016) - Ralph de Vere White, who steps down this week after a 32-year career at UC Davis Health System, has been honored with an educational endowment in his name. Wed, 29 Jun 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11275 Dorsey Griffith 2016-06-29T00:00:00Z Lung cancer patients who have surgery live longer https://www.ucdmc.ucdavis.edu/publish/news/cancer/11116/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11116 SACRAMENTO, Calif. (June 7, 2016) - Patients with late-stage, non-small cell lung cancer (NSCLC) who have surgery have better survival rates than those who don’t, but fewer of these patients are undergoing surgery, UC Davis researchers have found. Tue, 07 Jun 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11116 Dorsey Griffith 2016-06-07T00:00:00Z De Vere White to step down as long-time UC Davis Comprehensive Cancer Center director https://www.ucdmc.ucdavis.edu/publish/news/cancer/11166/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11166 SACRAMENTO, Calif. (May 31, 2016) - Ralph de Vere White, a beloved urologist and acclaimed researcher who led the UC Davis Comprehensive Cancer to designation by the National Cancer Institute (NCI), steps down as its long-time director on June 29. Tue, 31 May 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11166 Dorsey Griffith 2016-05-31T00:00:00Z Miglioretti awarded $7.5 million to evaluate supplemental breast imaging https://www.ucdmc.ucdavis.edu/publish/news/cancer/11153/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11153 SACRAMENTO, Calif. (May 25, 2016) - Diana Miglioretti, UC Davis dean’s professor of biostatistics and an internationally recognized breast cancer screening expert, has received $7.5 million to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies -- digital breast tomosynthesis (3D mammography) and magnetic resonance imaging (MRI) -- used with mammography for cancer detection. Miglioretti’s team also will work to determine whether effectiveness of the screening strategies depends on a woman’s breast density. Wed, 25 May 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11153 Dorsey Griffith 2016-05-25T00:00:00Z National Cancer Institute re-designates the cancer center https://www.ucdmc.ucdavis.edu/publish/news/cancer/11117/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11117 SACRAMENTO, Calif. (May 17, 2016) - The National Cancer Institute (NCI) has re-designated the UC Davis Comprehensive Cancer Center “comprehensive,” meaning that it meets stringent criteria in the areas of laboratory, clinical and population-based research, professional and public education and in the dissemination of clinical and public advances to the communities it serves. Tue, 17 May 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11117 Dorsey Griffith 2016-05-17T00:00:00Z Autism and cancer share a remarkable number of risk genes in common https://www.ucdmc.ucdavis.edu/publish/news/cancer/11057/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11057 SACRAMENTO, Calif. (May 3, 2016) - Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found. Tue, 03 May 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11057 2016-05-03T00:00:00Z Common supplement boosts kidney cancer therapy https://www.ucdmc.ucdavis.edu/publish/news/cancer/11042/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11042 SACRAMENTO, Calif. (May 2, 2016) - Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the May issue of the journal Molecular Cancer Therapeutics. Mon, 02 May 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11042 Dorsey Griffith 2016-05-02T00:00:00Z Targeted hepatitis B virus screening effective in addressing infection, liver disease risk https://www.ucdmc.ucdavis.edu/publish/news/cancer/11041/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11041 SACRAMENTO, Calif. (May 2, 2016) - A community-based hepatitis B virus screening effort led by UC Davis researchers found that targeted outreach to Asian American populations can identify groups at high risk for infection and direct them to appropriate follow-up care to help prevent the onset of liver diseases, including cancer. Mon, 02 May 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11041 Dorsey Griffith 2016-05-02T00:00:00Z SU2C awards Albeck Innovative Research Grant https://www.ucdmc.ucdavis.edu/publish/news/cancer/11026/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11026 SACRAMENTO, Calif. (April 26, 2016) - UC Davis molecular biologist John Albeck is among 10 recipients chosen to receive a 2016 Innovative Research Grant (IRG) from Stand Up to Cancer (SU2C), a non-profit that supports innovative, high-risk, high-reward projects to accelerate the pace of cancer research and give patients access to new therapies as quickly as possible. Tue, 26 Apr 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11026 Dorsey Griffith 2016-04-26T00:00:00Z UC Davis Comprehensive Cancer Center earns new quality certification https://www.ucdmc.ucdavis.edu/publish/news/cancer/11016/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_11016 SACRAMENTO, Calif. (April 20, 2016) - The UC Davis Comprehensive Cancer Center’s Division of Hematology/Oncology has been recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program for meeting the nation’s highest quality standards for cancer care. Wed, 20 Apr 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/11016 Susan Mar 2016-04-20T00:00:00Z UC Davis expands surgical care for lower GI diseases https://www.ucdmc.ucdavis.edu/publish/news/cancer/10994/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10994 SACRAMENTO, Calif. (April 20, 2016) - Linda Farkas, a surgeon and expert in hereditary cancers, has joined UC Davis Health System as a professor of surgery and chief of the newly created Division of Colon and Rectal Surgery. Wed, 20 Apr 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/10994 Susan Mar 2016-04-20T00:00:00Z International Cancer Genome Consortium for Medicine launch announced https://www.ucdmc.ucdavis.edu/publish/news/cancer/10997/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10997 New Orleans (April 17, 2016) - The International Cancer Genome Consortium (ICGC) today announced plans to launch of the International Cancer Genome Consortium for Medicine (ICGCmed), a new phase in the consortium’s evolution that will link genomics to clinical information and health. Sun, 17 Apr 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/10997 Dorsey Griffith 2016-04-17T00:00:00Z Radiation improves survival in older patients with soft tissue sarcomas https://www.ucdmc.ucdavis.edu/publish/news/cancer/10914/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10914 SACRAMENTO, Calif. (April 11, 2016) - UC Davis researchers have shown that radiation therapy following surgery benefits older patients more than their younger counterparts, a surprising finding that could change the way some patients are treated for soft tissue sarcomas (STS). Mon, 11 Apr 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/10914 Dorsey Griffith 2016-04-11T00:00:00Z New target makes end run against therapy-resistant prostate cancer https://www.ucdmc.ucdavis.edu/publish/news/cancer/10904/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10904 SACRAMENTO, Calif. (March 28, 2016) - Researchers at UC Davis, in collaboration with the other institutions, have found that suppressing the nuclear receptor protein ROR-γ with small-molecule compounds can reduce androgen receptor (AR) levels in castration-resistant prostate cancer and stop tumor growth. Mon, 28 Mar 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/10904 Dorsey Griffith 2016-03-28T00:00:00Z State stem cell agency approves research funding for UC Davis scientists https://www.ucdmc.ucdavis.edu/publish/news/cancer/10895/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10895 SACRAMENTO, Calif. (March 21, 2016) - Two new UC Davis research efforts, one aimed at addressing fatal early childhood conditions known as Tay-Sachs and Sandhoff disease, the other designed to develop an immunotherapy that would eradicate solid tumor cancer stem cells and create sustained anti-tumor effects, have been approved for funding by the California Institute for Regenerative Medicine (CIRM). Mon, 21 Mar 2016 00:00:00 PDT https://www.ucdmc.ucdavis.edu/publish/news/cancer/10895 Susan Mar 2016-03-21T00:00:00Z